Osteoporosis: The New Field for Dx/Rx Collaboration
Executive Summary
Pharmaceutical-diagnostic company alliances have had mixed results in the past, but both sides have greater incentives to work through differences. Nowhere is this more apparent than in the burgeoning field of osteoporosis disease management.